---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-017174"
form_type: "8-K"
ticker: "AXSM"
cik: "0001579428"
company_name: "Axsome Therapeutics, Inc."
filed_at: "2024-02-20T23:59:59+00:00"
generated_at: "2026-06-05T23:04:49.472541+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Axsome Therapeutics updates corporate presentation on February 20, 2024

## Summary
- Company posted updated corporate presentation to its website on February 20, 2024.
- Presentation filed as Exhibit 99.1; specific content not available in filing text.
- No financial results, clinical updates, or guidance changes disclosed in the 8-K.

## SEC filing metadata
- accession: 0000950170-24-017174
- form_type: 8-K
- ticker: AXSM
- cik: 0001579428
- company_name: Axsome Therapeutics, Inc.
- filed_at: 2024-02-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1579428/000095017024017174/0000950170-24-017174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1579428/000095017024017174/axsm-20240220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-017174
- JSON: https://secwatch.observer/filing/0000950170-24-017174.json
- Plain text: https://secwatch.observer/filing/0000950170-24-017174.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.